Australia’s National Health and Medical Research Council (NHMRC) has backed the use of puberty blockers in children presenting with gender dysphoria.
Its interim findings showed that “puberty suppressants were one possible part of care, and decisions about their use should be made through shared decision-making that involves the young person, their parents or carers and clinicians”.
Public consultation on the NHMRC’s interim advice is open until 18 January next year, with its full clinical guidelines to be developed by 2028.
This story has been republished with permission from RCR Bites. For news like this direct and free to your Inbox every day, go to biteme.news to sign up for RCR Bites.
If you are a media outlet interested in republishing RCR Bites stories, please contact inbox@rcr.media.